---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-106651"
form_type: "8-K"
ticker: "JSPR"
cik: "0001788028"
company_name: "Jasper Therapeutics, Inc."
filed_at: "2026-10-05T12:00:38+00:00"
generated_at: "2026-10-12T14:44:38.457107+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Jasper Therapeutics holders approve 1-for-15 to 1-for-35 reverse split and share increase to 675M

## Summary
- Proposal 1 approved 21,088,353 to 567,692 (91,820 abstentions): reverse stock split at a ratio of 1-for-15 to 1-for-35, at Board discretion any time on or before December 31, 2026.
- Proposal 2 approved 20,722,644 to 903,655 (121,566 abstentions): authorized common stock rises from 490,000,000 to 675,000,000 shares, effected at Board discretion.
- Proposal 3 (adjournment if needed) approved 20,938,915 to 528,123 (280,827 abstentions); all three proposals passed at the September 30, 2026 special meeting.
- 21,747,865 shares, roughly 65.36% of the 33,274,561 shares outstanding on the August 10, 2026 record date, were represented virtually or by proxy.
- Proposals were detailed in the definitive proxy statement filed with the SEC on September 4, 2026; split would not reduce the authorized share count.

## SEC filing metadata
- accession: 0001213900-26-106651
- form_type: 8-K
- ticker: JSPR
- cik: 0001788028
- company_name: Jasper Therapeutics, Inc.
- filed_at: 2026-10-05T12:00:38+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1788028/000121390026106651/0001213900-26-106651-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1788028/000121390026106651/ea0307484-8k_jasper.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-106651
- JSON: https://secwatch.observer/filing/0001213900-26-106651.json
- Plain text: https://secwatch.observer/filing/0001213900-26-106651.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.